Cargando…

High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival

SIMPLE SUMMARY: A recent point of focus in breast cancer (BC) research has been the utilization of cell-free DNA and its concentration (cfDConc) and integrity (cfDI) as potential biomarkers. Though the association of cfDConc and BC survival is already recognized, studies on the prognostic value of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamminaho, Maria, Kujala, Jouni, Peltonen, Hanna, Tengström, Maria, Kosma, Veli-Matti, Mannermaa, Arto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467852/
https://www.ncbi.nlm.nih.gov/pubmed/34572906
http://dx.doi.org/10.3390/cancers13184679
_version_ 1784573507348201472
author Lamminaho, Maria
Kujala, Jouni
Peltonen, Hanna
Tengström, Maria
Kosma, Veli-Matti
Mannermaa, Arto
author_facet Lamminaho, Maria
Kujala, Jouni
Peltonen, Hanna
Tengström, Maria
Kosma, Veli-Matti
Mannermaa, Arto
author_sort Lamminaho, Maria
collection PubMed
description SIMPLE SUMMARY: A recent point of focus in breast cancer (BC) research has been the utilization of cell-free DNA and its concentration (cfDConc) and integrity (cfDI) as potential biomarkers. Though the association of cfDConc and BC survival is already recognized, studies on the prognostic value of cfDI have had contradictory results. The aim of this study was to investigate the prognostic potential of cfDConc and cfDI in Eastern Finnish BC cases with a non-metastatic disease. While the prognostic value of cfDConc remained non-significant in our analyses, high cfDI was an independent prognostic factor for poor overall survival (OS) and breast cancer-specific survival (BCSS). Inclusion of cfDI in the multivariate logistic regression model improved the predictive performance of the model, thus suggesting that the combined use of traditional tumor features and liquid biopsy could help to discriminate BC patients with poor OS and BCSS more accurately at the time of diagnosis. ABSTRACT: Background: A recent point of focus in breast cancer (BC) research has been the utilization of cell-free DNA (cfDNA) and its concentration (cfDConc) and integrity (cfDI) as potential biomarkers. Though the association of cfDConc and poor survival is already recognized, studies on the prognostic value of cfDI have had contradictory results. Here, we provide further evidence to support the use of cfDI as a potential biomarker. Methods: We selected 204 Eastern Finnish BC cases with non-metastatic disease and isolated cfDNA from the serum collected at the time of diagnosis before any treatment was given. The cfDConc and cfDI were measured with a fluorometer and electrophoresis and analyzed with 25 years of survival data. Results: High cfDConc was not an independent prognostic factor in our analyses while high cfDI was found to be an independent prognostic factor for poor OS (p = 0.020, hazard ratio (HR) = 1.57, 95% confidence interval (CI) 1.07–2.29, Cox) and BCSS (p = 0.006, HR = 1.93, 95% CI 1.21–3.08)). Inclusion of cfDI in the multivariate logistic regression model improved the predictive performance. Conclusions: Our results show high cfDI is an independent prognostic factor for poor OS and BCSS and improves the predictive performance of logistic regression models, thus supporting its prognostic potential.
format Online
Article
Text
id pubmed-8467852
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84678522021-09-27 High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival Lamminaho, Maria Kujala, Jouni Peltonen, Hanna Tengström, Maria Kosma, Veli-Matti Mannermaa, Arto Cancers (Basel) Article SIMPLE SUMMARY: A recent point of focus in breast cancer (BC) research has been the utilization of cell-free DNA and its concentration (cfDConc) and integrity (cfDI) as potential biomarkers. Though the association of cfDConc and BC survival is already recognized, studies on the prognostic value of cfDI have had contradictory results. The aim of this study was to investigate the prognostic potential of cfDConc and cfDI in Eastern Finnish BC cases with a non-metastatic disease. While the prognostic value of cfDConc remained non-significant in our analyses, high cfDI was an independent prognostic factor for poor overall survival (OS) and breast cancer-specific survival (BCSS). Inclusion of cfDI in the multivariate logistic regression model improved the predictive performance of the model, thus suggesting that the combined use of traditional tumor features and liquid biopsy could help to discriminate BC patients with poor OS and BCSS more accurately at the time of diagnosis. ABSTRACT: Background: A recent point of focus in breast cancer (BC) research has been the utilization of cell-free DNA (cfDNA) and its concentration (cfDConc) and integrity (cfDI) as potential biomarkers. Though the association of cfDConc and poor survival is already recognized, studies on the prognostic value of cfDI have had contradictory results. Here, we provide further evidence to support the use of cfDI as a potential biomarker. Methods: We selected 204 Eastern Finnish BC cases with non-metastatic disease and isolated cfDNA from the serum collected at the time of diagnosis before any treatment was given. The cfDConc and cfDI were measured with a fluorometer and electrophoresis and analyzed with 25 years of survival data. Results: High cfDConc was not an independent prognostic factor in our analyses while high cfDI was found to be an independent prognostic factor for poor OS (p = 0.020, hazard ratio (HR) = 1.57, 95% confidence interval (CI) 1.07–2.29, Cox) and BCSS (p = 0.006, HR = 1.93, 95% CI 1.21–3.08)). Inclusion of cfDI in the multivariate logistic regression model improved the predictive performance. Conclusions: Our results show high cfDI is an independent prognostic factor for poor OS and BCSS and improves the predictive performance of logistic regression models, thus supporting its prognostic potential. MDPI 2021-09-18 /pmc/articles/PMC8467852/ /pubmed/34572906 http://dx.doi.org/10.3390/cancers13184679 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lamminaho, Maria
Kujala, Jouni
Peltonen, Hanna
Tengström, Maria
Kosma, Veli-Matti
Mannermaa, Arto
High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival
title High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival
title_full High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival
title_fullStr High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival
title_full_unstemmed High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival
title_short High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival
title_sort high cell-free dna integrity is associated with poor breast cancer survival
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467852/
https://www.ncbi.nlm.nih.gov/pubmed/34572906
http://dx.doi.org/10.3390/cancers13184679
work_keys_str_mv AT lamminahomaria highcellfreednaintegrityisassociatedwithpoorbreastcancersurvival
AT kujalajouni highcellfreednaintegrityisassociatedwithpoorbreastcancersurvival
AT peltonenhanna highcellfreednaintegrityisassociatedwithpoorbreastcancersurvival
AT tengstrommaria highcellfreednaintegrityisassociatedwithpoorbreastcancersurvival
AT kosmavelimatti highcellfreednaintegrityisassociatedwithpoorbreastcancersurvival
AT mannermaaarto highcellfreednaintegrityisassociatedwithpoorbreastcancersurvival